The paradox of the role of resistin in early-onset obesity hypertension: A comparative study among four Chinese adult subgroups

References

• Susic D, Obesity: VJ.A perspective from hypertension[J]. Med Clin North Am. 2017;101(1):139–57.
   PubMed Web of Science ®Google Scholar
• Nakamura K, J J F, Adipokines: WK.A link between obesity and cardiovascular disease[J]. J Cardiol. 2014;63(4):250–59.doi:10.1016/j.jjcc.2013.11.006.
   PubMed Web of Science ®Google Scholar
• Mostafazadeh M, Haiaty S, Rastqar A, et al. Correlation between resistin level and metabolic syndrome component: A review[J]. Horm Metab Res. 2018;50(7):521–36.doi:10.1055/a-0637-1975.
   PubMed Web of Science ®Google Scholar
• H K P, M K K, H J K, et al. Linking resistin, inflammation, and cardiometabolic diseases[J]. Korean J Intern Med. 2017;32(2):239–47.doi:10.3904/kjim.2016.229.
   PubMed Web of Science ®Google Scholar
• Badoer E, Kosari S, Stebbing MJ. Resistin, an adipokine with non-generalized actions on sympathetic nerve activity[J]. Front Physiol. 2015;6:321.doi:10.3389/fphys.2015.00321.
   PubMed Web of Science ®Google Scholar
• Kosari S, J A R, Chen F, et al. Centrally administered resistin enhances sympathetic nerve activity to the hindlimb but attenuates the activity to brown adipose tissue[J]. Endocrinology. 2011;152(7):2626–33.doi:10.1210/en.2010-1492.
   PubMed Web of Science ®Google Scholar
• Takata Y, Osawa H, Kurata M, et al. Hyperresistinemia is associated with coexistence of hypertension and type 2 diabetes[J]. Hypertension. 2008;51(2):534–39.doi:10.1161/HYPERTENSIONAHA.107.103077.
   PubMed Web of Science ®Google Scholar
• Thomopoulos C, Daskalaki M, Papazachou O, et al. Association of resistin and adiponectin with different clinical blood pressure phenotypes[J]. J Hum Hypertens. 2011;25(1):38–46.doi:10.1038/jhh.2010.22.
   PubMed Web of Science ®Google Scholar
• D P P, T K M, Perrea D, et al. Adiponectin–insulin and resistin plasma levels in young healthy offspring of patients with essential hypertension[J]. Blood Press. 2008;17(1):50–54.doi:10.1080/08037050701876307.
   PubMed Web of Science ®Google Scholar
• Zhang L, G C C, Forman JP.Plasma resistin levels associate with risk for hypertension among nondiabetic women[J]. J Am Soc Nephrol. 2010;21(7):1185–91.doi:10.1681/ASN.2009101053.
   PubMed Web of Science ®Google Scholar
• Gursoy G, Ulu S, Acar Y, et al. Relation of resistin with obesity and some cardiovascular risk factors in hypertensive women[J]. J Res Med Sci 2012;17:443–47.
   PubMed Web of Science ®Google Scholar
• M R S, H A C, W G E, et al. Relationships among insulin resistance, obesity, diagnosis of the metabolic syndrome and cardio-metabolic risk[J]. Diab Vasc Dis Res. 2011;8(2):109–16.doi:10.1177/1479164111403170.
   PubMed Web of Science ®Google Scholar
• O A M, Abdella NA.Associations of resistin with inflammation and insulin resistance in patients with type 2 diabetes mellitus[J]. Scand J Clin Lab Invest. 2007;67(2):215–25.doi:10.1080/00365510601032532.
   PubMed Web of Science ®Google Scholar
• C W Z, Y H G, W X S, et al. An update on the emerging role of resistin on the pathogenesis of osteoarthritis[J]. Mediators Inflamm. 2019;2019:1532164.
   PubMed Web of Science ®Google Scholar
• K G A, Zimmet PZ.Should we dump the metabolic syndrome? No[J]. BMJ. 2008;336(7645):641.doi:10.1136/bmj.39484.636586.94.
   PubMedGoogle Scholar
• Kang YS.Obesity associated hypertension: new insights into mechanism[J]. Electrolyte Blood Press. 2013;11(2):46–52.doi:10.5049/EBP.2013.11.2.46.
   PubMedGoogle Scholar
• Bokarewa M, Nagaev I, Dahlberg L, et al. Resistin, an adipokine with potent proinflammatory properties[J]. J Immunol. 2005;174(9):5789–95.doi:10.4049/jimmunol.174.9.5789.
   PubMed Web of Science ®Google Scholar
• Filkova M, Haluzik M, Gay S, et al. The role of resistin as a regulator of inflammation: implications for various human pathologies[J]. Clin Immunol. 2009;133(2):157–70.doi:10.1016/j.clim.2009.07.013.
   PubMed Web of Science ®Google Scholar
• Codoner-Franch P, Resistin: A-IE. Insulin resistance to malignancy[J]. Clin Chim Acta. 2015;438:46–54.doi:10.1016/j.cca.2014.07.043.
   PubMed Web of Science ®Google Scholar
• Silswal N, A K S, Aruna B, et al. Human resistin stimulates the pro-inflammatory cytokines tnf-alpha and il-12 in macrophages by nf-kappab-dependent pathway[J]. Biochem Biophys Res Commun. 2005;334(4):1092–101.doi:10.1016/j.bbrc.2005.06.202.
   PubMed Web of Science ®Google Scholar
• Kaser S, Kaser A, Sandhofer A, et al. Resistin messenger-rna expression is increased by proinflammatory cytokines in vitro[J]. Biochem Biophys Res Commun. 2003;309(2):286–90.doi:10.1016/j.bbrc.2003.07.003.
   PubMed Web of Science ®Google Scholar
• Tarkowski A, Bjersing J, Shestakov A, et al. Resistin competes with lipopolysaccharide for binding to toll-like receptor 4[J]. J Cell Mol Med. 2010;14(6B):1419–31.doi:10.1111/j.1582-4934.2009.00899.x.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Lu L, Hu Y, et al. Resistin induces hypertension and insulin resistance in mice via a tlr4-dependent pathway[J]. Sci Rep. 2016;6:22193.
   PubMed Web of Science ®Google Scholar
• Verma S, S H L, C H W, et al. Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction[J]. Circulation. 2003;108(6):736–40.doi:10.1161/01.CIR.0000084503.91330.49.
   PubMed Web of Science ®Google Scholar
• Chen C, Jiang J, J M L, et al. Resistin decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells[J]. Am J Physiol Heart Circ Physiol. 2010;299(1):H193–201. doi:10.1152/ajpheart.00431.2009.
   PubMed Web of Science ®Google Scholar
• Sadashiv TS, B N P, et al. Resistin gene expression in visceral adipose tissue of postmenopausal women and its association with insulin resistance[J]. Womens Health (Lond). 2012;8(5):521–28.doi:10.2217/WHE.12.46.
   PubMedGoogle Scholar
• Dominguez Coello S, Cabrera de Leon A, Almeida Gonzalez D, et al. Inverse association between serum resistin and insulin resistance in humans[J]. Diabetes Res Clin Pract. 2008;82(2):256–61.doi:10.1016/j.diabres.2008.08.001.
   PubMed Web of Science ®Google Scholar
• G P G, Provatopoulou X, Kalogera E, et al. Serum resistin is inversely related to breast cancer risk in premenopausal women[J]. Breast. 2016;29:163–69.
   PubMed Web of Science ®Google Scholar
• Tripathi D, Kant S, Pandey S, et al. Resistin in metabolism, inflammation, and disease[J]. Febs J. 2020;287(15):3141–49.doi:10.1111/febs.15322.
   PubMed Web of Science ®Google Scholar
• K Z S, Y R L, Zhang D, et al. Relation of circulating resistin to insulin resistance in type 2 diabetes and obesity: A systematic review and meta-analysis[J]. Front Physiol. 2019;10:1399.
   PubMed Web of Science ®Google Scholar
• Bajnok L, Seres I, Varga Z, et al. Relationship of serum resistin level to traits of metabolic syndrome and serum paraoxonase 1 activity in a population with a broad range of body mass index[J]. Exp Clin Endocrinol Diabetes. 2008;116(10):592–99.doi:10.1055/s-2008-1065350.
   PubMed Web of Science ®Google Scholar
• A V C, G L B, H R B, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the jnc 7 report[J]. JAMA. 2003;289(19):2560–72.doi:10.1001/jama.289.19.2560.
   PubMed Web of Science ®Google Scholar
• S K W, Ma W, Wang S, et al. Obesity and its relationship with hypertension among adults 50 years and older in jinan, china[J]. PLoS One. 2014;9(12):e114424.doi:10.1371/journal.pone.0114424.
   PubMed Web of Science ®Google Scholar
• S T A, B M M, G D P, et al. Waist circumference is better associated with high density lipoprotein (hdl-c) than with body mass index (bmi) in adults with metabolic syndrome[J]. Nutr Hosp. 2011;26(6):1328–32.doi:10.1590/S0212-16112011000600020.
   PubMed Web of Science ®Google Scholar
• Chen C, F C L.Department of disease control ministry of health P R C. The Guidelines for Prevention and Control of Overweight and Obesity in Chinese adults[J] Biomed Environ Sci. 2004;17(Suppl):1–36.
   PubMedGoogle Scholar
• Apovian CM.Obesity: definition, comorbidities, causes, and burden[J]. Am J Manag Care. 2016;22(7 Suppl):s176–185.
   PubMed Web of Science ®Google Scholar
• Lopatynski J, Mardarowicz G, Szczesniak G.A comparative evaluation of waist circumference, waist-to-hip ratio, waist-to-height ratio and body mass index as indicators of impaired glucose tolerance and as risk factors for type-2 diabetes mellitus[J]. Ann Univ Mariae Curie Sklodowska Med. 2003;58(1):413–19.
   PubMedGoogle Scholar
• Wu O, J H L, F F Y, et al. A comparative research on obesity hypertension by the comparisons and associations between waist circumference, body mass index with systolic and diastolic blood pressure, and the clinical laboratory data between four special chinese adult groups[J]. Clin Exp Hypertens. 2018;40(1):16–21.doi:10.1080/10641963.2017.1281940.
   PubMed Web of Science ®Google Scholar
• P G M, C M K, Resistin[J] KS, Lipidol CO. 2006. Curr Opin Lipidol. 17(2): 170–75. DOI:10.1097/01.mol.0000217899.59820.9a
   Google Scholar
• Acquarone E, Monacelli F, Borghi R, et al. Resistin: A reappraisal[J]. Mech Ageing Dev. 2019;178:46–63.
   PubMed Web of Science ®Google Scholar
• L L J, Li L, X F H, et al. Patients with nonalcoholic fatty liver disease display increased serum resistin levels and decreased adiponectin levels[J]. Eur J Gastroenterol Hepatol. 2009;21(6):662–66.doi:10.1097/MEG.0b013e328317f4b5.
   PubMed Web of Science ®Google Scholar
• C P R-L, M C G-T, Cruz-Bautista I, et al. Visceral obesity, skeletal muscle mass and resistin in metabolic syndrome development[J]. Nutr Hosp. 2019;36(1):43–50.doi:10.20960/nh.1889.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li Y, Yu L, et al. Association between serum resistin concentration and hypertension: A systematic review and meta-analysis[J]. Oncotarget. 2017;8(25):41529–37.doi:10.18632/oncotarget.17561.
   PubMedGoogle Scholar
• Diakowska D, Markocka-Maczka K, Szelachowski P, et al. Serum levels of resistin, adiponectin, and apelin in gastroesophageal cancer patients[J]. Dis Markers. 2014;2014:619649.
   PubMed Web of Science ®Google Scholar
• Krecki R, Krzeminska-Pakula M, Drozdz J, et al. Relationship of serum angiogenin, adiponectin and resistin levels with biochemical risk factors and the angiographic severity of three-vessel coronary disease[J]. Cardiol J 2010;17:599–606.
   PubMed Web of Science ®Google Scholar
• Cabrera de Leon A, Almeida Gonzalez D, Gonzalez Hernandez A, et al. The association of resistin with coronary disease in the general population[J]. J Atheroscler Thromb. 2014;21(3):273–81.doi:10.5551/jat.19273.
   PubMed Web of Science ®Google Scholar
• D J W, Strand M, Rask E, et al. Intra-adipose sex steroid metabolism and body fat distribution in idiopathic human obesity[J]. Clin Endocrinol (Oxf). 2007;66(3):440–46.doi:10.1111/j.1365-2265.2007.02755.x.
   PubMed Web of Science ®Google Scholar
• R M W, Shiang T, Al Sayah L, et al. Arterial stiffening precedes systolic hypertension in diet-induced obesity[J]. Hypertension. 2013;62(6):1105–10.doi:10.1161/HYPERTENSIONAHA.113.01744.
   PubMed Web of Science ®Google Scholar
• B M K, Rong J, M G L, et al. Aortic stiffness, blood pressure progression, and incident hypertension[J]. JAMA. 2012;308(9):875–81.doi:10.1001/2012.jama.10503.
   PubMed Web of Science ®Google Scholar
• M E S, L M VB, Struijker-Boudier HA.Resistance and conduit arteries following converting enzyme inhibition in hypertension[J]. J Vasc Res. 1997;34(2):67–81.doi:10.1159/000159204.
   PubMed Web of Science ®Google Scholar
• Uchida H, Nakamura Y, Kaihara M, et al. Practical efficacy of telmisartan for decreasing morning home blood pressure and pulse wave velocity in patients with mild-to-moderate hypertension[J]. Hypertens Res. 2004;27(8):545–50.doi:10.1291/hypres.27.545.
   PubMed Web of Science ®Google Scholar
• Fujie S, Hasegawa N, Sato K, et al. Aerobic exercise training-induced changes in serum adropin level are associated with reduced arterial stiffness in middle-aged and older adults[J]. Am J Physiol Heart Circ Physiol. 2015;309(10):H1642–1647. doi:10.1152/ajpheart.00338.2015.
   PubMed Web of Science ®Google Scholar
• N W R, G A H, Kaye DM.Say no to obesity-related hypertension: role of the l-arginine-nitric oxide pathway[J]. Hypertension. 2016;67(5):813–19.doi:10.1161/HYPERTENSIONAHA.116.06778.
   PubMed Web of Science ®Google Scholar
• Roush GC.Obesity-induced hypertension: heavy on the accelerator[J]. J Am Heart Assoc. 2019;8(8):e012334.doi:10.1161/JAHA.119.012334.
   PubMed Web of Science ®Google Scholar
• A L C, Fernandes A, J A A-P, et al. Towards frailty biomarkers: candidates from genes and pathways regulated in aging and age-related diseases[J]. Ageing Res Rev. 2018;47:214–77.
   PubMed Web of Science ®Google Scholar
• K H K, Lee K, Y S M, et al. A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation[J]. J Biol Chem. 2001;276(14):11252–56.doi:10.1074/jbc.C100028200.
   PubMed Web of Science ®Google Scholar
• C M S, Lazar MA.The current biology of resistin[J]. J Intern Med. 2004;255(4):439–47.doi:10.1111/j.1365-2796.2004.01306.x.
   PubMed Web of Science ®Google Scholar
• J E H, Do Carmo JM, da Silva AA, et al. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms[J]. Circ Res. 2015;116(6):991–1006.doi:10.1161/CIRCRESAHA.116.305697.
   PubMed Web of Science ®Google Scholar
• Zhang M, Cui H, B P Z, et al. Association of serum resistin with cystatin c and urinary albumin-to-creatinine ratio in elderly chinese men with essential hypertension[J]. Postgrad Med J. 2015;91(1073):132–37.doi:10.1136/postgradmedj-2013-132408.
   PubMed Web of Science ®Google Scholar
• Joksic J, Sopic M, Spasojevic-Kalimanovska V, et al. Circulating resistin protein and mrna concentrations and clinical severity of coronary artery disease[J]. Biochem Med (Zagreb). 2015;25(2):242–51.doi:10.11613/BM.2015.025.
   PubMed Web of Science ®Google Scholar
• Dimitriadis K, Tsioufis C, Selima M, et al. Independent association of circulating resistin with glomerular filtration rate in the early stages of essential hypertension[J]. J Hum Hypertens. 2009;23(10):668–73.doi:10.1038/jhh.2009.12.
   PubMed Web of Science ®Google Scholar
• Marouga A, Dalamaga M, A N K, et al. Correlates of serum resistin in elderly, non-diabetic patients with chronic kidney disease[J]. Clin Lab. 2013;59(9–10):1121–28. doi:10.7754/Clin.Lab.2012.121112.
   PubMed Web of Science ®Google Scholar
• Zhou L, Yu X, Meng Q, et al. Resistin reduces mitochondria and induces hepatic steatosis in mice by the protein kinase c/protein kinase g/p65/ppar gamma coactivator 1 alpha pathway[J]. Hepatology. 2013;57(4):1384–93.doi:10.1002/hep.26167.
   PubMed Web of Science ®Google Scholar
• A A B, Lokhandwala MF.Renal dopamine oxidation and inflammation in high salt fed rats[J]. J Am Heart Assoc. 2020;9(1):e014977.doi:10.1161/JAHA.119.014977.
   PubMed Web of Science ®Google Scholar
• Ackermann A, M S F-A, Sanchez de Rojas R, et al. Modulation of angiotensin-converting enzyme by nitric oxide[J]. Br J Pharmacol. 1998;124(2):291–98.doi:10.1038/sj.bjp.0701836.
   PubMed Web of Science ®Google Scholar
• Persson K, P A W, Nyhlen K, et al. Nitric oxide donors and angiotensin-converting enzyme inhibitors act in concert to inhibit human angiotensin-converting enzyme activity and platelet aggregation in vitro[J]. Eur J Pharmacol. 2000;406(1):15–23.doi:10.1016/S0014-2999(00)00647-6.
   PubMed Web of Science ®Google Scholar
• Marcelino-Rodriguez I, Almeida Gonzalez D, J J A-S, et al. Inverse association of resistin with physical activity in the general population[J]. PLoS One. 2017;12(8):e0182493.doi:10.1371/journal.pone.0182493.
   PubMed Web of Science ®Google Scholar
• D A Z, Biernat W, Barc J. Roles of leptin and resistin in metabolism, reproduction, and leptin resistance[J]. Domest Anim Endocrinol.2020;73:106472.doi:10.1016/j.domaniend.2020.106472.
   PubMed Web of Science ®Google Scholar